Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERASE-MI: PRT060128 Before Primary PCI in STEMI Patients
NCT00546260Phase 2Terminated
- Sponsor
- Alexion Pharmaceuticals
- Start
- Nov 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of elinogrel in myocardial infarction (MI), sponsored by Alexion Pharmaceuticals. Started Nov 2007; status: terminated.
02
Drugs
elinogrel
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00546260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546260.